Healthcare - Quarterly Net Income Analysis

Last updated 2024-12-21 20:04:26 (EST)

Quarterly Net Income Trend Analysis

Overall Quarterly Net Income Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Net Income vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)

FindBillion.com

Seasonally Adjusted Quarterly Net Income Growth Rate


QoQ Growth Rate of Net Income	14.8%
YoY Growth Rate of Net Income	-16.5%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly net income of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Healthcare Seasonally Adjusted Quarterly Net Income vs. Stock Price for Healthcare Sector

Healthcare Seasonally Adjusted Quarterly Net Income and stock price of Healthcare Sector show a Low Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Healthcare Seasonally Adjusted Quarterly Net Income and Stock Price

Low Correlation 0.18

FindBillion.com

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker	Name	QoQ Growth Rate of Seasonally Adjusted Quarterly Revenue	YoY Growth Rate of Seasonally Adjusted Quarterly Revenue
ARGX	argenx SE	Turn Losses into Profits	Turn Loss into Profit
BAX	Baxter International Inc.	Turn Losses into Profits	-94.4%
BIO	Bio-Rad Laboratories, Inc.	Turn Losses into Profits	514.7%
BNTX	BioNTech SE	Turn Losses into Profits	23.3%
ELAN	Elanco Animal Health Incorporated	Turn Losses into Profits	Turn Loss into Profit
ILMN	Illumina, Inc.	Turn Losses into Profits	Turn Loss into Profit
IMGN	ImmunoGen, Inc.	Turn Losses into Profits	Turn Loss into Profit
INCY	Incyte Corporation	Turn Losses into Profits	-37.8%
MRNA	Moderna, Inc.	Turn Losses into Profits	Turn Loss into Profit
PEN	Penumbra, Inc.	Turn Losses into Profits	220.5%
QGEN	Qiagen N.V.	Turn Losses into Profits	26%
RETA	Reata Pharmaceuticals, Inc.	Turn Losses into Profits	Turn Loss into Profit
SGFY	Signify Health, Inc.	Turn Losses into Profits	1754.6%
VRTX	Vertex Pharmaceuticals Incorporated	Turn Losses into Profits	1%
VTRS	Viatris Inc.	Turn Losses into Profits	-71.4%
PFE	Pfizer Inc.	20827.9%	Turn Loss into Profit
RPRX	Royalty Pharma plc	1006.9%	654.3%
EW	Edwards Lifesciences Corporation	679.9%	697.8%
SRPT	Sarepta Therapeutics, Inc.	507%	Turn Loss into Profit
THC	Tenet Healthcare Corporation	316.7%	367.3%
BRKR	Bruker Corporation	251.2%	-53.6%
SNN	Smith & Nephew plc	235.3%	20.9%
AMGN	Amgen Inc.	211.2%	63.6%
GRFS	Grifols, S.A.	152.2%	-13.9%
ABMD	Abiomed, Inc.	145.5%	86.4%
SWAV	ShockWave Medical, Inc.	137%	41.5%
ALC	Alcon Inc.	106.6%	28.9%
JAZZ	Jazz Pharmaceuticals plc	99.8%	46.5%
CAH	Cardinal Health, Inc.	86.7%	8220%
INSP	Inspire Medical Systems, Inc.	76.3%	Turn Loss into Profit
GMED	Globus Medical, Inc.	74.7%	5094%
STVN	Stevanato Group S.p.A.	64.8%	-20.8%
TAK	Takeda Pharmaceutical Company Limited	61.7%	Turn Loss into Profit
LNTH	Lantheus Holdings, Inc.	61.4%	-0.7%
SNY	Sanofi	56.6%	11.5%
WST	West Pharmaceutical Services, Inc.	53.5%	-15.7%
UNH	UnitedHealth Group Incorporated	53.1%	3.7%
NVS	Novartis AG	46.7%	81.1%
BSX	Boston Scientific Corporation	46.3%	-7.1%
SOLV	Solventum Corporation	45.1%	-57.2%
BDX	Becton, Dickinson and Company	41.6%	289.8%
BDXA	Becton, Dickinson and Company	41.6%	289.8%
BDXB	Becton, Dickinson and Company	41.6%	289.8%
COO	The Cooper Companies, Inc.	40%	39.1%
NVO	Novo Nordisk A/S	38.9%	21.5%
ALGN	Align Technology, Inc.	34.1%	-4.5%
RVTY	Revvity, Inc.	33.6%	883.3%
IDXX	IDEXX Laboratories, Inc.	32.4%	9.7%
ICLR	ICON Public Limited Company	32%	20.4%
HALO	Halozyme Therapeutics, Inc.	31.9%	67.4%
NBIX	Neurocrine Biosciences, Inc.	30.5%	56.2%
ABT	Abbott Laboratories	29.4%	14.6%
MMSI	Merit Medical Systems, Inc.	28.9%	10.1%
ATR	AptarGroup, Inc.	23.9%	18.7%
FMS	Fresenius Medical Care AG & Co. KGaA	23.6%	152.5%
MOH	Molina Healthcare, Inc.	22.6%	33.1%
MEDP	Medpace Holdings, Inc.	19.9%	36.8%
STE	STERIS plc	15.5%	30.1%
WAT	Waters Corporation	15.5%	20%
GEHC	GE HealthCare Technologies Inc.	14.4%	25.6%
UHS	Universal Health Services, Inc.	13.8%	54.9%
ENSG	The Ensign Group, Inc.	13.7%	22.8%
TMO	Thermo Fisher Scientific Inc.	9.4%	-5%
DVA	DaVita Inc.	8.6%	-13%
MDT	Medtronic plc	8.6%	39.7%
RMD	ResMed Inc.	8%	41.9%
VEEV	Veeva Systems Inc.	6.6%	37.5%
A	Agilent Technologies, Inc.	0.7%	-26.1%
HCA	HCA Healthcare, Inc.	-0.1%	17.7%
TECH	Bio-Techne Corporation	-2.5%	-34.1%
HLN	Haleon plc	-5.5%	1.7%
DHR	Danaher Corporation	-6.5%	-27.5%
HOLX	Hologic, Inc.	-6.9%	97.1%
ISRG	Intuitive Surgical, Inc.	-8.1%	35.9%
DXCM	DexCom, Inc.	-8.7%	11.5%
GMAB	Genmab A/S	-9.2%	-40.5%
CHE	Chemed Corporation	-9.6%	1.1%
REGN	Regeneron Pharmaceuticals, Inc.	-11%	33%
EHC	Encompass Health Corporation	-11.3%	26.8%
MTD	Mettler-Toledo International Inc.	-11.8%	4.9%
ZTS	Zoetis Inc.	-12.1%	14.4%
SYK	Stryker Corporation	-12.8%	20.5%
PKI	PerkinElmer, Inc.	-14.6%	-80.2%
DGX	Quest Diagnostics Incorporated	-18.3%	0.4%
CNC	Centene Corporation	-18.8%	52%
UTHR	United Therapeutics Corporation	-19%	15.5%
ABC	AmerisourceBergen Corporation	-19.1%	25.4%
HSIC	Henry Schein, Inc.	-20%	-27.7%
BIIB	Biogen Inc.	-22.5%	Turn Loss into Profit
TFX	Teleflex Incorporated	-23%	-19.1%
DOCS	Doximity, Inc.	-23.9%	44.3%
EXEL	Exelixis, Inc.	-26.5%	11232.7%
CRL	Charles River Laboratories International, Inc.	-26.9%	-21.4%
ABBV	AbbVie Inc.	-27%	-12.2%
LH	Laboratory Corporation of America Holdings	-30.9%	-7.6%
GILD	Gilead Sciences, Inc.	-34.1%	-42.5%
RDY	Dr. Reddy's Laboratories Limited	-35.2%	-15.2%
ANTM	Elevance Health Inc.	-37.4%	-21.2%
ELV	Elevance Health Inc.	-37.4%	-21.2%
HUM	Humana Inc.	-38.6%	-42.3%
AZN	AstraZeneca PLC	-42%	4%
CI	Cigna Corporation	-43%	1702.4%
BMRN	BioMarin Pharmaceutical Inc.	-43.6%	162.7%
MASI	Masimo Corporation	-44.5%	-7.5%
IQV	IQVIA Holdings Inc.	-44.8%	-5.9%
JNJ	Johnson & Johnson	-45.3%	-89.6%
ZBH	Zimmer Biomet Holdings, Inc.	-46.7%	53.2%
MRK	Merck & Co., Inc.	-55.1%	-33.5%
LLY	Eli Lilly and Company	-63%	Turn Loss into Profit
BMY	Bristol-Myers Squibb Company	-63.1%	-37.2%
PODD	Insulet Corporation	-66.3%	49.3%
MCK	McKesson Corporation	-67.5%	-63.7%
HQY	HealthEquity, Inc.	-78.2%	-61.1%
PHG	Koninklijke Philips N.V.	-78.8%	105.7%
CVS	CVS Health Corporation	-94.6%	-96.2%
COR	Cencora	-99.3%	-99%
CTLT	Catalent, Inc.	-100%	-
GSK	GSK plc	-100%	-100%
RGEN	Repligen Corporation	-100%	-100%
WBA	Walgreens Boots Alliance, Inc.	-100%	-
ALNY	Alnylam Pharmaceuticals, Inc.	-	-100%
ASND	Ascendis Pharma A/S	-	-
BGNE	BeiGene, Ltd.	-	-100%
BLCO	Bausch + Lomb Corporation	-	-
BPMC	Blueprint Medicines Corporation	-	-
CERE	Cerevel Therapeutics Holdings, Inc.	-	-
CYTK	Cytokinetics, Incorporated	-	-
EXAS	Exact Sciences Corporation	-	-100%
GKOS	Glaukos Corporation	-	-
INSM	Insmed Incorporated	-	-
IONS	Ionis Pharmaceuticals, Inc.	-	-
ITCI	Intra-Cellular Therapies, Inc.	-	-
KRTX	Karuna Therapeutics, Inc.	-	-
LEGN	Legend Biotech Corporation	-	-
MDGL	Madrigal Pharmaceuticals, Inc.	-	-
MESO	Mesoblast Limited	-	-
NTRA	Natera, Inc.	-	-
NUVL	Nuvalent, Inc.	-	-
OSH	Oak Street Health, Inc.	-	-
PCVX	Vaxcyte, Inc.	-	-
RCM	R1 RCM Inc.	-	-100%
RVMD	Revolution Medicines, Inc.	-	-
RXDX	Prometheus Biosciences, Inc.	-	-
SGEN	Seagen Inc.	-	-
SMMT	Summit Therapeutics Inc.	-	-
TEVA	Teva Pharmaceutical Industries Limited	-	-100%
ROIV	Roivant Sciences Ltd.	-	-

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.